199 related articles for article (PubMed ID: 27479182)
1. Survival control of malignant lymphocytes by anti-apoptotic MCL-1.
Fernández-Marrero Y; Spinner S; Kaufmann T; Jost PJ
Leukemia; 2016 Nov; 30(11):2152-2159. PubMed ID: 27479182
[TBL] [Abstract][Full Text] [Related]
2. Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance.
Spinner S; Crispatzu G; Yi JH; Munkhbaatar E; Mayer P; Höckendorf U; Müller N; Li Z; Schader T; Bendz H; Hartmann S; Yabal M; Pechloff K; Heikenwalder M; Kelly GL; Strasser A; Peschel C; Hansmann ML; Ruland J; Keller U; Newrzela S; Herling M; Jost PJ
Leukemia; 2016 Jul; 30(7):1520-30. PubMed ID: 27055871
[TBL] [Abstract][Full Text] [Related]
3. [A study on the expression of myeloid cell leukemia 1 proteins and survivin and their relation with B cell apoptosis in non-Hodgkin's lymphoma].
Zuo XL; Zhou X; Meng J; Zhang KJ; Liu XH; Yang HQ
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):133-5. PubMed ID: 16624124
[TBL] [Abstract][Full Text] [Related]
4. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
[TBL] [Abstract][Full Text] [Related]
5. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.
Grabow S; Delbridge AR; Aubrey BJ; Vandenberg CJ; Strasser A
Cell Rep; 2016 Mar; 14(10):2337-47. PubMed ID: 26947081
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?
Williams MM; Cook RS
Oncotarget; 2015 Feb; 6(6):3519-30. PubMed ID: 25784482
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.
Krajewski S; Bodrug S; Gascoyne R; Berean K; Krajewska M; Reed JC
Am J Pathol; 1994 Sep; 145(3):515-25. PubMed ID: 8080035
[TBL] [Abstract][Full Text] [Related]
8. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
9. MCL-1 expression in B-cell non-Hodgkin's lymphomas.
Cho-Vega JH; Rassidakis GZ; Admirand JH; Oyarzo M; Ramalingam P; Paraguya A; McDonnell TJ; Amin HM; Medeiros LJ
Hum Pathol; 2004 Sep; 35(9):1095-100. PubMed ID: 15343511
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
[TBL] [Abstract][Full Text] [Related]
11. Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis.
Grabow S; Kelly GL; Delbridge AR; Kelly PN; Bouillet P; Adams JM; Strasser A
Cell Death Dis; 2016 Mar; 7(3):e2132. PubMed ID: 26962682
[TBL] [Abstract][Full Text] [Related]
12. MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice.
Grabow S; Delbridge AR; Valente LJ; Strasser A
Blood; 2014 Dec; 124(26):3939-46. PubMed ID: 25368374
[TBL] [Abstract][Full Text] [Related]
13. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
14. A conserved mechanism for binding of p53 DNA-binding domain and anti-apoptotic Bcl-2 family proteins.
Lee DH; Ha JH; Kim Y; Jang M; Park SJ; Yoon HS; Kim EH; Bae KH; Park BC; Park SG; Yi GS; Chi SW
Mol Cells; 2014 Mar; 37(3):264-9. PubMed ID: 24646834
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MCL-1 by obatoclax sensitizes Sp2/0-Ag14 hybridoma cells to glutamine deprivation-induced apoptosis.
Harnett CC; Abusneina A; Clément J; Gauthier ER
Cell Biochem Funct; 2015 Jul; 33(5):334-40. PubMed ID: 26178811
[TBL] [Abstract][Full Text] [Related]
16. Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
Tanaka T; Kikuchi N; Goto K; Iino M
Apoptosis; 2016 May; 21(5):594-608. PubMed ID: 26892009
[TBL] [Abstract][Full Text] [Related]
17. Endogenous association of Bim BH3-only protein with Mcl-1, Bcl-xL and Bcl-2 on mitochondria in human B cells.
Gomez-Bougie P; Bataille R; Amiot M
Eur J Immunol; 2005 Mar; 35(3):971-6. PubMed ID: 15724238
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 family proteins and leukemia. Minireview.
Kusenda J
Neoplasma; 1998; 45(3):117-22. PubMed ID: 9717521
[TBL] [Abstract][Full Text] [Related]
19. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.
Ambroise G; Portier A; Roders N; Arnoult D; Vazquez A
Oncotarget; 2015 Nov; 6(35):38181-94. PubMed ID: 26431330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]